Article Download - ejbps

1 downloads 0 Views 545KB Size Report
Jun 20, 2015 - intraperitoneal injection of 60 mg/kg STZ dissolved in 0.1 M sodium citrate buffer at pH 4.5. The rats had free access to 5% of glucose water and ...
ejbps, 2015, Volume 2, Issue 4,538-551.

Research Article

SJIF Impact Factor 2.062

European Journal of Biomedical AND Pharmaceutical sciences http://www.ejbps.com

ISSN 2349-8870 Volume: 2 Issue: 4 538-551 Year: 2015

ANTIDIABETIC, ANTIHYPERLIPIDAEMIC AND ANTIOXIDANT ACTIVITIES OF LEAVES OF LEUCAS LINIFOLIA SPRENG IN STREPTOZOTOCIN INDUCED DIABETIC RATS Dr. Mukundam Borah*1 and Dr. Swarnamoni Das2 1

Demonstrator (MD, Pharmacology), Department of Pharmacology, Gauhati Medical College & Hospital, Guwahati, Assam, PIN-781032. 2

Professor & Head, Department of Pharmacology, Assam Medical College and Hospital, Dibrugarh, Assam, PIN-786002.

Article Received on 09/06/2015

Article Revised on 20/06/2015

Article Accepted on 21/07/2015

ABSTRACT *Correspondence for

Objectives: The leaves of Leucas linifolia Spreng. are used in folk

Author Dr. Mukundam Borah

medicine to treat diabetes. The objective of the study was to evaluate

Demonstrator (MD,

the antidiabetic, anti-hyperlipidemic and anti-oxidant activities of the

Pharmacology), Department

ethanolic extract of the leaves of Leucas linifolia Spreng. (EELL) in

of Pharmacology, Gauhati

streptozotocin induced diabetic rats. Materials & Methods: Male

Medical College & Hospital,

Wistar albino rats (150–200g) were administered single intraperitoneal

Guwahati, Assam, PIN-

injection of STZ (60 mg/kg b.w. i.p) to induce diabetes. Albino rats

781032.

(n=25) were divided into five groups of five animals each. Group I (Normal control) and Group II (Diabetic control) received normal saline (10ml / kg / day p.o) whereas Group III and Group IV received 250 mg/kg/day and 500 mg/kg/day p.o of EELL respectively for two weeks. Group V (Diabetic standard) received 6 U/kg /day s.c of NPH insulin. Biochemical estimations of fasting blood sugar, serum insulin, catalase, malondialdehyde and serum lipid profile were performed on 1st, 8th and 15th day. Effect of EELL on intestinal glucose absorption was also evaluated. Results: Group II exhibited significant rise in blood glucose, serum cholesterol, triglycerides, Low density lipoprotein, serum malondialdehyde levels and decrease in serum insulin, catalase and High density lipoprotein levels. EELL treated groups showed reversal of these changes significantly (p